Cargando…

Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM

BACKGROUND: Clinical studies have shown that the efficacy of programmed cell death receptor-1/programmed cell death ligand-1 (PD-1/PD-L1) inhibitors on glioblastoma (GBM) is much lower than what is expected because of the low immunogenicity of GBM. Ferroptosis of cancer cells can induce the maturati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Bao, Ji, Qifeng, Cheng, Ying, Liu, Miao, Zhang, Bangle, Mei, Qibing, Liu, Daozhou, Zhou, Siyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962245/ https://www.ncbi.nlm.nih.gov/pubmed/35351131 http://dx.doi.org/10.1186/s12951-022-01360-6

Ejemplares similares

MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer
por: Bai, Shaobo, et al.
Publicado: (2021)

Tregs biomimetic nanoparticle to reprogram inflammatory and redox microenvironment in infarct tissue to treat myocardial ischemia reperfusion injury in mice
por: Li, Fangyuan, et al.
Publicado: (2022)

Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice
por: Liu, Daozhou, et al.
Publicado: (2022)

Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
por: Nair, Smita K, et al.
Publicado: (2013)

Differentiation of Human GBM From Non-GBM Brain Tissue With Polarization Imaging Technique
por: Liu, Yi-Rong, et al.
Publicado: (2022)

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM
por: Feng, Songshan, et al.
Publicado: (2022)

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
por: Van Gool, Stefaan W., et al.
Publicado: (2020)

LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM
por: Fu, Haijuan, et al.
Publicado: (2022)

Anti-GBM-Nephritis
por: Windpessl, Martin, et al.
Publicado: (2023)

Drug Screening of Human GBM Spheroids in Brain Cancer Chip
por: Akay, Metin, et al.
Publicado: (2018)

Diagnosis of Diabetes Mellitus Using Gradient Boosting Machine (LightGBM)
por: Rufo, Derara Duba, et al.
Publicado: (2021)

Fully automatic GBM segmentation in the TCGA-GBM dataset: Prognosis and correlation with VASARI features
por: Rios Velazquez, Emmanuel, et al.
Publicado: (2015)

Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells
por: Mukherjee, Sumit, et al.
Publicado: (2018)

Comparision of Piceid and Resveratrol in Antioxidation and Antiproliferation Activities In Vitro
por: Su, Dan, et al.
Publicado: (2013)

Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges
por: Han, Ying, et al.
Publicado: (2023)

Corrigendum to “Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges” [Redox Biol. 63 (2023) 102734]
por: Han, Ying, et al.
Publicado: (2023)

Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines
por: Binder, Zev A., et al.
Publicado: (2016)

Advances in nanotechnology for the treatment of GBM
por: Wei, Dongyan, et al.
Publicado: (2023)

Anti-GBM disease with a mild relapsing course and low levels of anti-GBM autoantibodies
por: Segelmark, Mårten, et al.
Publicado: (2012)

A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening
por: Stackhouse, Christian T., et al.
Publicado: (2019)

In Vitro and In Vivo Antitumor Activity of a Novel pH-Activated Polymeric Drug Delivery System for Doxorubicin
por: Huan, Menglei, et al.
Publicado: (2012)

Transformation of membranous into anti-GBM nephritis
por: Imtiaz, S., et al.
Publicado: (2012)

Mitochondrial DNA Alterations in Glioblastoma (GBM)
por: Leão Barros, Mariceli Baia, et al.
Publicado: (2021)

The Role of Myeloid Cells in GBM Immunosuppression
por: Lin, Ya-Jui, et al.
Publicado: (2022)

Targeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM
por: Liu, Ching-Ann, et al.
Publicado: (2022)

LGBMDF: A cascade forest framework with LightGBM for predicting drug-target interactions
por: Peng, Yu, et al.
Publicado: (2023)

Histone H3 Phosphorylation in GBM: a New Rational to Guide the Use of Kinase Inhibitors in anti-GBM Therapy
por: Pacaud, Romain, et al.
Publicado: (2015)

Anti-GBM disease with positive serum anti-GBM antibodies but negative IgG deposition: A case report
por: Kazemzadeh, Kimia, et al.
Publicado: (2023)

Podocyte Depletion in Thin GBM and Alport Syndrome
por: Wickman, Larysa, et al.
Publicado: (2016)

Re-thinking the preclinical development of GBM therapeutics
por: Cosset, Érika, et al.
Publicado: (2018)

Fingolimod Augments Monomethylfumarate Killing of GBM Cells
por: Dent, Paul, et al.
Publicado: (2020)

Using Light for Therapy of Glioblastoma Multiforme (GBM)
por: Vasilev, Alex, et al.
Publicado: (2020)

FAM72, Glioblastoma Multiforme (GBM) and Beyond
por: Ho, Nguyen Thi Thanh, et al.
Publicado: (2021)

Engineering Adenoviral Vectors with Improved GBM Selectivity
por: Bates, Emily A., et al.
Publicado: (2023)

Predicting Metabolite–Disease Associations Based on LightGBM Model
por: Zhang, Cheng, et al.
Publicado: (2021)

Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening
Publicado: (1986)

CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo
por: Meng, Wei, et al.
Publicado: (2018)

Selective anti-tumor activity of the novel fluoropyrimidine polymer F10 towards G48a orthotopic GBM tumors
por: Gmeiner, William H., et al.
Publicado: (2013)

Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models
por: Zhang, Huiyuan, et al.
Publicado: (2023)

Assessing the Role of STAT3 in DC Differentiation and Autologous DC Immunotherapy in Mouse Models of GBM
por: Assi, Hikmat, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1k5j5m486idsl5o0q7bcgqkjgo